3M Company EPI-0037 Page 1 of 25 FINAL REPORT Epidemiology, 220-6W-08 Medical Department 3M Company St.
refid# 3QyXVoyKaQdy2oZ4ZX31p41Ya46 pages
ST-279 ToxDocs 10-014 TOXICOLOGY ASSESSMENT AND COMPLIANCE ASSURANCE GROUP 3M COMPANY 10-014: ADME Study of MTDI+D 207 (Potassium Perfluorohexanesulfonate, K"PFHXxS) in Mice FINAL REPORT ToxDoces Study Number 10-014 Lot Number(s) 118993-109 Strategic Tox Lab Study Number | ST-279 Other Identification Number(s) L-9051 | | || 19F/IH-NMR Analytical `GID Number Study Director Report|No GID numberassigned; see Appendix 1 for Certificate of Analysis Jill Hart, AAS, LATg Laboratory Administrator Principle Investigator: (Study Monitor) John Butenhoff, Ph.D, DABT, CIH Corporate Scientist | Testing Facility lL [| In-Life Start Date L os In-Life Termination Date ~ [3M Strategic Toxicology Laboratory 3M Center,Bldg 270, room SB314 Saint Paul, MN 55144 February 1,2010 | July 20,2010 lof 12 ST-279 ToxDoes 10-014 TOXICOLOGY ASSESSMENT3MANCDOCMOPMAPNLYIANCE ASSURANCE GROUP 10-014: ADME Study of MTDID 207 (Potassium Perfluorohexanesulfonate, K'PFHxS) in Mice Compliance Statement and Signature Page This study was conducted for research and development purposes and does not conform 10 regulatory guidelines.
refid# YDgEwbMnEzy4V02ZB1ba2a4dN12 pages
DETERMINA5TIOTNHEOFSTHHAEKEWAFLTAESRKSMOELTUBHIOLDITY OF PFOS WILDLIFEINTERNATIONAL LTD, PROJECTNUMBER. 454C-107 /C-5 `OECD Guideline for the TesoftChi emin calgs, 105.
refid# X86arJZQmvnx52NKrXRLV7L5w35 pages
I Centre Analytical Laboratories, Inc
refid# 0N83xXwz0Oorr6D7eXLqb6ox8 pages
J .
refid# 3e4323mO8YLzeqy9pn8eN2QvJ18 pages
Fe-129 : Jo Submitted to: - BIOSEARCH INC.
refid# j6RGjMgnbkn4N7eV3LZJw52k3 pages
SoEPA =z NOTE Toh SUBJECT: PowerPoint Presentation: EPA Activites/lssues on Fluorosurfactants Hp FROM: Mary F.
refid# zb0evQvxELYE8NxNop1RKrEQn4 pages
me and Medical Discos MR226- -- 1l0o 22 ar Smt.PnauliMNe$51;333220 } ) me ts 3M May 24, 2001 Se"7na-os:or- 00373 UBUTR An Simi Carine| BEHP-F0-37 0OsMtSuse sw ERR Dear 8() Coordinator: believed to represent information which meet the reporting threshold for section8()of 2, 5, and 20 parts per million (ppm) plus an additional "recovery" group at 20 ppm for Soman, Ts sa on one orvotes Tap, Regards, Z Zabel, MD MPH StaffVice President & Medical Director e: Dr.
refid# e7Mq26y3vwgnpoM6DqneeQjL92 pages
- 226 - 1IS2 n#H Te - STUDY TITLE Analysis of Pooled Human Sera and Plasma and Monkey Sera for Fluorocarbons Using - Exygen Method ExM-023-071 DATA REQUIREMENTS .
refid# 0gV5Rv6zyvGmNG6LqpZo6Bgbx110 pages
AR226 - 1198 FINALREPORT.
refid# jBvKV0oXGyeJddYX8o51RV5LO31 pages
: AR 236 - 1263 _-- DuDPuoPonnttEEMMSSEERReeppoornttNNoo..1133:-0033 Study Title READY BIODEGRADATION OF 8-2 TELOMER B ALCOHOL (MODIFIED OECD 301D CLoseD BOTTLE TesT) Test Guideline COrhgeamniiczaaltsi;onSefcotrioEnco3:noRmeiacdyanBdioCdoeogpreardaatbiilvtey:Dev30e1loDpmCelnotse(dOEBCotDt)eTGeuisdtel(1i9n9e2)f.or Testing of Author Ning Wang, Ph.D.
refid# wrKekee68RRMDK45ggnp0N4gJ28 pages
ARA26 -- 1239 Telomer Research Program FP AGC = Clariant.
refid# 3R31oNpN7jq15M7JL8MzdV3611 pages
AR226-1342 DuPont-9478 TRADE SECRET Study Title 8-2 Telomer B Alcohol: Subchronic Toxicity 90-Day Oral Gavage Study in Rats Volume 1 of 3 Laboratory Project ID: DuPont-9478 TEST GUIDELINES: U.S.
refid# VxM0BeDKEr0djKx01RxjDwmN967 pages
AR286- | Hk c sgt..
refid# dn5pK9ByZM1rJ3m10Zy0dY50e6 pages
EEE 200 F-Y 050I 0- 1378 AtteacheststoanLtetOtetrhertoICn.foArumeartidoanteadn MCaeryai18n, 2000 AR126-0377 Perfluorooctane Sulfonate-Related Compounds `Bibliography Showing Studies in 3M's Possession Believed To Be In FIFRA Docket.
refid# 5bp7KLaMeb5yLw2wR2LX1kxN82 pages